8th Jul 2014 09:12
LONDON (Alliance News) - EKF Diagnostics Holdings PLC said Tuesday it has signed a new distribution contract with Tiajin Multiclone Trading Co in China for its glucose and lactate analyser Biosen C-Line.
The contract is worth around EUR4 million over a two-and-half-year period, and as the customer will also need to buy consumables for the analyser, a further EUR2.0 million in revenue could be generated from the contract over the same period, EKF said.
Additionally, the company's German partner won regulatory approval in China and Japan for its CompoLab TS haemoglobin instrument, which EKF said expanded its sales reach and paved the way for further growth across Asia.
Shares in EKF were trading up 3.3% at 27.62 pence Tuesday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Ekf Diagnostics